Verdad Advisers’s Tenet Healthcare THC Stock Holding History

Verdad Advisers’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,809	Closed	-$507K	–	135
2024 Q2	$507K	Buy	+3,809	New	+$459K	0.59%	75

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Verdad Advisers's THC Position: Q3 2024 in Review

Verdad Advisers sold out of Tenet Healthcare (THC) in Q3 2024, closing a stake of 3,809 shares — an estimated $507K sold.

Verdad Advisers first reported a position in THC in Q2 2024 and held it in 1 quarter. The position peaked at $507K in Q2 2024. 603 funds tracked by Wall St. Rank hold THC as of Q3 2024.

Verdad Advisers reported no remaining Tenet Healthcare position as of Q3 2024 after selling out during the quarter.
Verdad Advisers sold 3,809 Tenet Healthcare shares in Q3 2024, an estimated $507K.
Verdad Advisers first reported a position in Tenet Healthcare in Q2 2024 and held it in 1 quarter.
Verdad Advisers's Tenet Healthcare position peaked at $507K in Q2 2024.
603 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2024.

Based on Verdad Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.